Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease

BACKGROUND: Extramammary Paget's disease (EMPD) is a rare skin cancer and sometimes has fatal prognosis. For progressive cases, therapeutic options are limited. In recent years, treatment with an anti-programmed death-1 (PD-1) antibody has improved the prognosis of various malignancies. In addi...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Hiroyuki, Sugita, Kazunari, Yamamoto, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208280/
https://www.ncbi.nlm.nih.gov/pubmed/34188273
http://dx.doi.org/10.4103/ijd.IJD_341_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208280/
https://www.ncbi.nlm.nih.gov/pubmed/34188273
http://dx.doi.org/10.4103/ijd.IJD_341_18

Ejemplares similares